MA26446A1 - Derives de vinylpyrrolidinone de cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation. - Google Patents

Derives de vinylpyrrolidinone de cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation.

Info

Publication number: MA26446A1
Authority: MA; Morocco
Prior art keywords: lower alkyl; hydrogen; phenyl; hydroxy; optionally substituted
Prior art date: 1996-11-06

Application number

MA24852A

Other languages

English (en)

Inventor

Angehrn Peter

Heinze-Krauss Ingrid

G F Richter Hans

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-06

Filing date

1997-11-03

Publication date

2004-12-20

1997-11-03 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26446A1 publication Critical patent/MA26446A1/fr

Links

229930186147 Cephalosporin Natural products 0.000 title abstract 2
229940124587 cephalosporin Drugs 0.000 title abstract 2
150000001780 cephalosporins Chemical class 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 11
229910052739 hydrogen Inorganic materials 0.000 abstract 7
239000001257 hydrogen Substances 0.000 abstract 7
125000000623 heterocyclic group Chemical group 0.000 abstract 6
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 5
150000002431 hydrogen Chemical class 0.000 abstract 5
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 5
150000001875 compounds Chemical class 0.000 abstract 4
229910052736 halogen Inorganic materials 0.000 abstract 4
150000002367 halogens Chemical class 0.000 abstract 4
125000001624 naphthyl group Chemical group 0.000 abstract 4
125000003342 alkenyl group Chemical group 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000003282 alkyl amino group Chemical group 0.000 abstract 2
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000004104 aryloxy group Chemical group 0.000 abstract 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000005504 styryl group Chemical group 0.000 abstract 2
208000035473 Communicable disease Diseases 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
125000005157 alkyl carboxy group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
-1 carboxy, amino Chemical group 0.000 abstract 1
125000006244 carboxylic acid protecting group Chemical group 0.000 abstract 1
125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Photoreceptors In Electrophotography (AREA)
Separation Using Semi-Permeable Membranes (AREA)

MA24852A 1996-11-06 1997-11-03 Derives de vinylpyrrolidinone de cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation. MA26446A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96117710		1996-11-06
EP97115996		1997-09-15

Publications (1)

Publication Number	Publication Date
MA26446A1 true MA26446A1 (fr)	2004-12-20

Family

ID=26142279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24852A MA26446A1 (fr)	1996-11-06	1997-11-03	Derives de vinylpyrrolidinone de cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation.

Country Status (18)

Country	Link
US (1)	US6294668B1 (fr)
EP (1)	EP0841339B1 (fr)
JP (1)	JP3065289B2 (fr)
KR (1)	KR100273611B1 (fr)
CN (1)	CN1081639C (fr)
AT (1)	ATE354577T1 (fr)
AU (1)	AU727014B2 (fr)
CA (1)	CA2220188C (fr)
CZ (1)	CZ350197A3 (fr)
DE (1)	DE69737382T2 (fr)
DK (1)	DK0841339T3 (fr)
ES (1)	ES2281090T3 (fr)
HU (1)	HUP9701835A3 (fr)
IL (1)	IL122098A0 (fr)
MA (1)	MA26446A1 (fr)
NO (1)	NO975094L (fr)
NZ (1)	NZ329106A (fr)
SG (1)	SG71055A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150350A (en) *	1997-09-15	2000-11-21	Hoffman-La Roche Inc.	Antimicrobial compositions
US6232306B1 (en)	1998-06-15	2001-05-15	Hoffmann-La Roche Inc.	Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams
ATE231871T1 (de) *	1998-06-15	2003-02-15	Basilea Pharmaceutica Ag	3-(2-oxo-(1,3')bipyrrolidinyl-3-yliden-methyl)- cephemderivate
KR100414336B1 (ko)	1998-06-22	2004-01-07	바실리어 파마슈티카 아게	프로페닐 세팔로스포린 유도체
AU1654900A (en) *	1998-12-03	2000-06-19	F. Hoffmann-La Roche Ag	Bi-pyrrolidinylvinl (carba) cephalosporins
AU6267100A (en) *	1999-07-07	2001-01-30	F. Hoffmann-La Roche Ag	Vinylpyrrolidinone derivatives with substituted thiazole ring
KR100931744B1 (ko) *	2000-02-15	2009-12-14	히다치 가세고교 가부시끼가이샤	접착제 조성물, 그 제조 방법, 이것을 이용한 접착 필름, 반도체 탑재용 기판 및 반도체 장치
WO2006010978A1 (fr) *	2004-06-30	2006-02-02	Wockhardt Limited	Formes polymorphes de cefdinir, et son sel d'imidazole
JP2010504281A (ja) *	2006-07-27	2010-02-12	エミスフェアー・テクノロジーズ・インク	アリールスルファニル化合物、および活性薬剤を送達するための組成物
MX2011001333A (es) *	2008-08-04	2011-03-15	Astrazeneca Ab	Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad.
WO2010116177A1 (fr)	2009-04-09	2010-10-14	Astrazeneca Ab	Dérivé de pyrazolo [4,5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
WO2010116176A1 (fr)	2009-04-09	2010-10-14	Astrazeneca Ab	Dérivé de pyrazolo [4, 5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
ES2565952T3 (es)	2009-05-25	2016-04-07	Sandoz Ag	Método para la producción de ceftobiprol medocaril
UY35103A (es)	2012-10-29	2014-05-30	Glaxo Group Ltd	Compuestos de cefem 2-sustituidos
CN111471058A (zh) *	2019-01-23	2020-07-31	中国医学科学院药物研究所	用于制备头孢吡普类似物的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4255423A (en) *	1977-07-27	1981-03-10	Merck & Co., Inc.	Cephalosporin compounds
FR2457296A1 (fr)	1979-05-23	1980-12-19	Rhone Poulenc Ind	Nouveaux derives de vinyl-3 cephalosporines et leur preparation
IL94946A0 (en)	1989-07-13	1991-06-10	Eisai Co Ltd	3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
EP0416810B1 (fr)	1989-09-04	1995-02-08	Beecham Group p.l.c.	Dérivés de céphalosporine, leur procédé de préparation, compositions pharmaceutiques et intermédiaires
MY106991A (en)	1989-09-04	1995-08-30	Pfizer	Novel cephalosporin derivatives or compounds
GB9019743D0 (en)	1990-09-10	1990-10-24	Beecham Group Plc	Novel compounds
JPH08502513A (ja)	1992-10-23	1996-03-19	藤沢薬品工業株式会社	セフェム化合物、およびそれらの医薬組成物
US5523400A (en)	1993-04-16	1996-06-04	Hoffmann-La Roche Inc.	Cephalosporin antibiotics
PT620225E (pt) *	1993-04-16	2003-03-31	Basilea Pharmaceutica Ag	Derivados de cefalosporina
US5827845A (en)	1993-09-29	1998-10-27	Meiji Seika Kaisha, Ltd.	Cephalosporin derivative
US5559108A (en)	1994-09-02	1996-09-24	Bristol-Myers Squibb Company	Cephalosporin derivatives
US5567698A (en)	1995-02-15	1996-10-22	Bristol-Myers Squibb Company	Pyridinium thiomethyl substituted chepholosporin derivatives
JPH11501017A (ja) *	1995-02-27	1999-01-26	エフ・ホフマン−ラロシュアーゲー	３−ピロリジリデン−２−オン−セファロスポリンの誘導体
JPH08319291A (ja)	1995-05-25	1996-12-03	Meiji Seika Kaisha Ltd	新規セフェム誘導体
AT403161B (de)	1995-07-19	1997-11-25	Biochemie Gmbh	Verfahren zur herstellung von cephemverbindungen
EP0761673A1 (fr) *	1995-09-12	1997-03-12	F. Hoffmann-La Roche Ag	Dérivés de céphalosporine
US5883247A (en)	1996-06-10	1999-03-16	Hoffmann-La Roche Inc.	Preparation of cephem and isooxacephem derivatives
EP0831093A1 (fr)	1996-09-23	1998-03-25	F. Hoffmann-La Roche Ag	Dérivés de 1-carba-(déthia)-céphalosporine

1997
- 1997-10-29 DE DE69737382T patent/DE69737382T2/de not_active Expired - Lifetime
- 1997-10-29 ES ES97118780T patent/ES2281090T3/es not_active Expired - Lifetime
- 1997-10-29 DK DK97118780T patent/DK0841339T3/da active
- 1997-10-29 AT AT97118780T patent/ATE354577T1/de active
- 1997-10-29 EP EP97118780A patent/EP0841339B1/fr not_active Expired - Lifetime
- 1997-11-03 MA MA24852A patent/MA26446A1/fr unknown
- 1997-11-04 CA CA002220188A patent/CA2220188C/fr not_active Expired - Fee Related
- 1997-11-04 IL IL12209897A patent/IL122098A0/xx unknown
- 1997-11-04 NZ NZ329106A patent/NZ329106A/xx unknown
- 1997-11-05 NO NO975094A patent/NO975094L/no not_active Application Discontinuation
- 1997-11-05 US US08/964,640 patent/US6294668B1/en not_active Expired - Fee Related
- 1997-11-05 CN CN97122431A patent/CN1081639C/zh not_active Expired - Fee Related
- 1997-11-05 AU AU44356/97A patent/AU727014B2/en not_active Ceased
- 1997-11-05 HU HU9701835A patent/HUP9701835A3/hu unknown
- 1997-11-05 KR KR1019970058137A patent/KR100273611B1/ko not_active Expired - Fee Related
- 1997-11-05 CZ CZ973501A patent/CZ350197A3/cs unknown
- 1997-11-05 SG SG1997003954A patent/SG71055A1/en unknown
- 1997-11-06 JP JP9304115A patent/JP3065289B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP9701835A3 (en)	2001-04-28
HU9701835D0 (en)	1997-12-29
NO975094D0 (no)	1997-11-05
EP0841339A1 (fr)	1998-05-13
SG71055A1 (en)	2000-03-21
IL122098A0 (en)	1998-04-05
KR19980042094A (ko)	1998-08-17
CA2220188C (fr)	2008-04-08
US6294668B1 (en)	2001-09-25
JP3065289B2 (ja)	2000-07-17
AU4435697A (en)	1998-05-14
CN1181382A (zh)	1998-05-13
ES2281090T3 (es)	2007-09-16
HUP9701835A2 (hu)	1999-05-28
CA2220188A1 (fr)	1998-05-06
CZ350197A3 (cs)	1998-05-13
EP0841339B1 (fr)	2007-02-21
JPH10139783A (ja)	1998-05-26
AU727014B2 (en)	2000-11-30
CN1081639C (zh)	2002-03-27
NO975094L (no)	1998-05-07
KR100273611B1 (ko)	2000-12-15
DE69737382T2 (de)	2007-10-31
DE69737382D1 (de)	2007-04-05
NZ329106A (en)	1998-12-23
DK0841339T3 (da)	2007-07-02
ATE354577T1 (de)	2007-03-15

Publication	Publication Date	Title
ATE354577T1 (de)	2007-03-15	Vinylpyrrolidinon-cephalosporin-derivate
NO882036L (no)	1988-11-14	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
NO178697C (no)	1996-05-15	Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser
NO882608D0 (no)	1988-06-14	Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
ES2197160T3 (es)	2004-01-01	Antagonistas fibronogeno bicicliclos.
IL109321A0 (en)	1994-07-31	Cephalosporin derivatives, their manufacture and pharmaceutical compositions containing them
RU94012924A (ru)	1995-12-20	Производные цефалоспорина
AU1060592A (en)	1992-08-06	N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3,2,1)octanes, intermediates and a process for the preparation thereof and their use as medicaments
DE69217613D1 (de)	1997-04-03	Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ES2106439T3 (es)	1997-11-01	5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
DK1209166T3 (da)	2004-07-26	Hidtil ukendte A-500 359-derivater
ES2001031A6 (es)	1988-04-16	Un procedimiento para la preparacion de penicilinas que contienen un grupo oximino
JPH11140087A5 (fr)	2005-11-04
MX9708525A (es)	1998-05-31	Derivados de vinilpirrolidinon-cefalosporina.
ES2005778A6 (es)	1989-03-16	Procedimiento para la obtencion de derivados de diisobutilxantina.
RU97118647A (ru)	1999-08-10	Винилпирролидиноновые производные цефалоспорина